Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 76282-407

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 76282-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Sevelamer Carbonate Tabs 800mg)

Label for Sevelamer Carbonate Tablets 800 mg by Exelan Pharmaceuticals Inc. The film-coated oral tablets come in a package of 270. The label includes the product NDC 76282-407, barcode, QR code, and storage instructions, noting protection from moisture and controlled room temperature conditions. It lists inactive ingredients and the manufacturers' information.*

FDA Label Image

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)

Chemical structure diagram of sevelamer carbonate, showing polymeric units with ammonium groups and bicarbonate ions. The structure includes different repeating segments labeled as a, b, and c, representing the polymer backbone and functional groups.*

FDA Label Image

Figure 2 (Sevelamer Carbonate Tabs Fig02)

A line graph comparing percentage of patients achieving various levels of reduction in serum phosphorus (mg/dL) from baseline, for Sevelamer Hydrochloride versus Active Control. The x-axis shows reduction in serum phosphorus ranging from -4 to 8 mg/dL, and the y-axis shows the percentage of patients with at least that reduction, from 0 to 100%. Negative values indicate worsened increase, positive values indicate improved reduction.*

FDA Label Image

Figure 3 (Sevelamer Carbonate Tabs Fig03)

A line graph showing phosphorus change from baseline on the vertical axis versus study week on the horizontal axis. It compares Sevelamer Hydrochloride (black circles) and an Active-Control (red squares) over 52 weeks, illustrating trends in phosphorus levels during the study period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.